Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.69 |
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 4/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8167761 | 0.95 | CYP1A2 (0.77) | CYP1A2PPARGGRM2EPHX1ALDH1A1 | |
| SCHEMBL192113 | 0.95 | CYP1A2 (0.67) | CYP1A2PPARGTP53GRM2EPHX1 | |
| SCHEMBL9192649 | 0.95 | CYP1A2 (0.77) | CYP1A2PPARGGRM2EPHX1ALDH1A1 | |
| SCHEMBL114875 | 0.95 | CYP1A2 (0.77) | CYP1A2PPARGGRM2EPHX1ALDH1A1 | |
| SCHEMBL15657235 | 0.93 | CYP1A2 (0.65) | CYP1A2PPARGTP53GRM2EPHX1 | |
| SCHEMBL4445694 | 0.93 | CYP1A2 (0.81) | CYP1A2PPARGGRM2EPHX1ALDH1A1 | |
| SCHEMBL1171612 | 0.93 | CYP1A2 (0.65) | CYP1A2PPARGTP53GRM2EPHX1 | |
| SCHEMBL1744226 | 0.93 | CYP1A2 (0.81) | CYP1A2PPARGGRM2EPHX1ALDH1A1 | |
| SCHEMBL1254547 | 0.93 | CYP1A2 (0.81) | CYP1A2PPARGGRM2EPHX1ALDH1A1 | |
| SCHEMBL114922 | 0.93 | CYP1A2 (0.81) | CYP1A2PPARGGRM2EPHX1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 464 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | claimed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | claimed |
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-113873884-B | Arthropod control composition | 弗门尼舍有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| US-20230148641-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | claimed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | claimed |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| EP-1214972-B1 | Method for preparing lactone | DAIREN CHEMICAL CORP (TW) | 2003-06-04 | — | — | EP | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| EP-1214972-A1 | Method for preparing lactone | Dairen Chemical Corporation (TW) | 2002-06-19 | — | — | EP | claimed |
| EP-1201652-A1 | Process for the preparation of lactams | Dairen Chemical Corporation (TW) | 2002-05-02 | — | — | EP | claimed |
| US-6350883-B1 | REACTION OF LACTONE WITH AMINE OR AMMONIA TO FORM A LACTAM | DAIREN CHEMICAL CORPORATION (TW) | 2002-02-26 | — | — | US | claimed |
| US-6323347-B2 | USED FOR DEHYDROCYCLIZATION REACTION OF A DIOL UNDER A GAS PHASE TO FORM LACTONE; ACTIVITY, LONG LIFETIME AND HIGH SELECTIVITY OF PRODUCTS | DAIREN CHEMICAL CORPORATION (TW) | 2001-11-27 | — | — | US | claimed |
| US-20010009964-A1 | Catalyst for preparing lactone and a method for preparing lactone | DAIREN CHEMICAL CORPORATION (TW) | 2001-07-26 | — | — | US | claimed |
| EP-0152082-B1 | AN ORGANIC SEMICONDUCTOR ELECTROLYTE CAPACITOR AND PROCESS FOR PRODUCING THE SAME | NIPPON CHEMI-CON CORPORATION (JP) | 1989-05-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | CNOT9, MSL1, MT-CO2 | CYP1A2 841/4885PPARG 4028/4885TP53 4879/4885 |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | CYP1A2 640/4885PPARG 192/4885TP53 117/4885 |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | AGO2, NOP2, FBL | CYP1A2 926/4885PPARG 4170/4885TP53 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.